Pembrolizumab plus axitinib: a new treatment option for patients with metastatic renal cell carcinoma
- PMID: 31280574
- DOI: 10.21037/cco.2019.04.05
Pembrolizumab plus axitinib: a new treatment option for patients with metastatic renal cell carcinoma
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources